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Elsevier Taiwan LLC. Open access under CSummary A 48-year-old male presented with diffuse abdominal fullness for 1 month and tea-
colored urine for 10 days. Abdominal computed tomography/magnetic resonance cholangio-
pancreatography revealed diffuse enlargement of the pancreas and unusual soft tissue density
around the left ureter. Endoscopic retrograde cholangiopancreatography demonstrated lumen
narrowing of the distal common bile duct and irregularity of the pancreatic duct. Markedly
elevated serum immunoglobulin G4 (IgG4) was also noted. Biopsy of soft tissue from the area
surrounding the left ureter identified lymphoplasmacytic infiltration with high concentrations
of IgG4-positive plasma cells accompanied by obliterative phlebitis, compatible with IgG4-
related disease. The patient was administered steroid therapy and his symptoms improved.
Clinicians should be aware of possible IgG4-related disease in a patient presenting with
obstructive jaundice and diffuse pancreatic enlargement because glucocorticoid administra-
tion can achieve good response.
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Immunoglobulin G4-related disease (IgG4-RD) is increas-
ingly recognized as a syndrome of unknown etiology con-
sisting of a collection of disorders that are characterized by
tumefactive lesions, dense lymphoplasmacytic infiltrate
rich in IgG4-positive plasma cells, storiform fibrosis, and,
often but not always, elevated serum IgG4 concentration
[1]. This disease adversely affects one or more organs,an and The Digestive Endoscopy Society of Taiwan. Published by
IgG4-related disease 61including the biliary trees, salivary glands, periorbital tis-
sues, and kidneys. This report describes an unusual case of
a patient with IgG4-RD of the pancreas and retro-
peritoneum with clinical manifestation as obstructive
jaundice.Figure 2 Infiltrate soft tissue around the left common iliac
artery (arrows).Case report
A 48-year-old male with no history of major medical prob-
lems complained of abdominal fullness for 1 month, and of
tea-colored urine and yellowish skin discoloration with
itching for 10 days. He also lost about 6 kg body weight in 2
weeks. Fever, chills, abdominal pain, clay-colored stool,
constipation, diarrhea, urinary frequency, low back pain,
and melena were not reported.
Physical examination showed icteric sclera, generalized
yellowish discoloration of skin, and no abnormal finding was
found. Laboratory data included 8.1  109/L white blood
cells (normal, 4.0e10.0  109/L), 55 U/L aspartate
aminotransferase (normal, <35 U/L), 181 U/L alanine
aminotransferase (normal, <40 U/L), 349 IU/L alkaline
phosphatase (normal, <128 IU/L), 356 U/L ɣ-glutamyl-
transferase (normal, <60 U/L), 9.1 mg/dL total bilirubin
(normal, <1.6 mg/dL), and 80 U/L amylase (normal,
30e110 U/L). Marked elevated serum IgG4 was also noted
(5660 mg/L; normal, 39.2e864 mg/dL). Abdominal
computed tomography (CT) and magnetic resonance chol-
angiopancreatography demonstrated diffuse enlargement
of the pancreas with dilatation of the biliary tree and
without pancreatic duct dilatation (Fig. 1). An unusual
infiltrating soft tissue around the left common iliac artery
causing left hydronephrosis and hydroureter was noted also
(Fig. 2). Percutaneous transhepatic biliary drainage was
performed for jaundice relief by an emergency physician.
Endoscopic retrograde cholangiopancreatography showed
narrowing of the lower common bile duct and pancreatic
duct lumen (Fig. 3). A plastic stent (preloaded Cot-
toneLeung biliary stent, C741707, 7F, 7 cm) was implanted
for biliary drainage. Several days later, a linear endoscopic
ultrasound identified marked swelling of the pancreatic
head and body with heterogeneous echogenicity and noFigure 1 Enhanced computed tomography shows diffuse enlar
(arrows).pancreatic duct dilatation. A biopsy of pancreatic tissue
was not performed due to patient intolerance. Biopsy of
the soft tissue surrounding the left ureter was done under
CT guidance, and histopathological examination showed
diffuse lymphoplasmacytic infiltration of soft tissue and
obliterative phlebitis with a positive IgG4 stain over the
plasma cell (Fig. 4). Hence, the patient was administered
methylprednisolone 40 mg/day initially and his symptoms
improved. A repeat abdominal CT examination showed that
his pancreas and soft tissue near the left common iliac ar-
tery had shrunk after treatment for 3 months. (Fig. 5)Discussion
IgG4-RD can involve one or multiple organs. The disease
was initially recognized in the pancreas, a disease now
known as autoimmune pancreatitis, type 1 [2]. To our
knowledge, some patients have been diagnosed withgement of the pancreas without pancreatic duct dilatation
Figure 3 (A) Cholangiogram via percutaneous transhepatic cholangial drainage shows lumen narrowing noted at the distal end;
the contrast could flow into the duodenum (arrow). (B) Diffuse lumen narrowing of the pancreatic duct is noted (arrow).
62 Y.-R. Li et al.autoimmune pancreatitis with extrapancreatic manifesta-
tion (especially sclerosing cholangitis) in Taiwan [3,4], or
received an operation due to clinically suspected malig-
nancy. The disorder seems very uncommon, but the syn-
drome is now increasingly recognized in every organ
system.
The epidemiology of IgG4-RD remains poorly described
due to its low prevalence. Notably, IgG4-RD involving the
intra-abdominal organs often occurs in men who are
middle-aged or older. However, IgG4-related sialadenitis
has a more equal gender distribution [5,6]. Patients typi-
cally present with development of a mass in the affected
organ or diffuse enlargement of the organ. As many as 40%
of patients with IgG4-RD have allergic diseases such as
asthma [7].
The gold standard diagnosis is based on pathologic
findings. The critical features of IgG4-RD are dense lym-
phoplasmacytic infiltrate, storiform fibrosis, and oblitera-
tive phlebitis, and it affects tissues with a predominance of
IgG4-positive plasma cells and T lymphocytes. The mini-
mum for making the diagnosis for most tissues is 30e50
IgG4-positive cells/high-power field [2]. The disease is
generally accompanied by an elevated serum level of IgG4
[2,8]. Less than 40% of patients have normal serum IgG4Figure 4 (A) Histological examination shows patchy aggregates
(B) Immunohistochemistry of immunoglobulin G4 is strongly positivconcentrations, although classic histopathological findings
for involved tissues are present [9].
A standard treatment for IgG4-RD has not been estab-
lished. Although IgG4-RD treatment is based on observa-
tional data, almost all have focused on treatment duration
for autoimmune pancreatitis, which respond well to glu-
cocorticoids therapy. Glucocorticoids are typically the first
line of therapy, as in this case. In some studies, adminis-
tration of glucocorticoids was discontinued within 3
months, but treatment continued for 3 years in other
studies [10,11]. Although the initial outcome achieved with
glucocorticoids is satisfactory, disease flare-ups are com-
mon. Azathioprine, mycophenolate mofetil, and metho-
trexate are used alternatively for refractory patients;
however, their efficacy has not been proven.
This report presents a rare case of a patient who pre-
sented with abdominal fullness and painless jaundice. The
CT and magnetic resonance cholangiopancreatography
showed an enlarged pancreas without pancreatic duct
dilatation, and a retroperitoneal mass. Histological exami-
nation results were compatible with IgG4-RD. Clinicians
should be aware of possible IgG4-RD when faced with
abdominal fullness, painless jaundice, recurrent pancrea-
titis, or other related symptoms.of lymphocytes and numerous plasma cells (100, arrows).
e (100).
Figure 5 After 3 months of treatment, enhanced computed tomography shows (A) a decrease in the swelling of the pancreas
(arrow) and (B) soft tissue around the left common iliac artery (arrow).
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